Kobe City Medical Center General Hospital — Biomedical Watch V2

Essais liés7clinical trials

VilleKobelocalisation

PaysJapanlocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05648500

Ouvrir le site du centre

Essais cliniques associés

7

Molécule	Indication / population	Phase	NCT	Titre	Statut
Amivantamab	Cancer	Phase 3	NCT04538664	PAPILLON — A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions	ACTIVE_NOT_RECRUITING
Donanemab	Alzheimer	Phase 3	NCT04437511	A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)	ACTIVE_NOT_RECRUITING
Elranatamab	Cancer	Phase 3	NCT06152575	MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)	RECRUITING
JNJ-64042056	Alzheimer	Phase 2	NCT06544616	Reτain — A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease	ACTIVE_NOT_RECRUITING
Cenerimod	Lupus	Phase 3	NCT05648500	OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus	ACTIVE_NOT_RECRUITING
Pozelimab + Cemdisiran	Myasthénie	Phase 3	NCT05070858	NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination Therapy and Cemdisiran Alone Are and How Well They Work in Adult Patients With Generalized Myasthenia Gravis	ACTIVE_NOT_RECRUITING
Pembrolizumab	Parkinson	Phase 3	NCT03358472	Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)	COMPLETED